2014
DOI: 10.1111/jcmm.12412
|View full text |Cite
|
Sign up to set email alerts
|

The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC

Abstract: In contrast to cancer cells, most normal human cells have no or low telomerase levels which makes it an attractive target for anti-cancer drugs. The small molecule sulforaphane from broccoli is known for its cancer therapeutic potential in vitro and in vivo. In animals and humans it was found to be quickly metabolized into 4-methylthiobutyl isothiocyanate (MTBITC, erucin) which we recently identified as strong selective apoptosis inducer in hepatocellular carcinoma (HCC) cells. Here, we investigated the releva… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(15 citation statements)
references
References 40 publications
0
15
0
Order By: Relevance
“…We saw stronger HDAC inhibition by ECN than SFN, which is the most commonly studied of cruciferous vegetable phytochemical metabolites. Perhaps a stronger focus on ECN as a potential epigenetic modulator would be fruitful as it can be found at high concentrations in other cruciferous vegetables such as arugula [41, 42]. To the best of our knowledge, this is the first report of HDAC inhibition by erucin.…”
Section: Discussionmentioning
confidence: 91%
“…We saw stronger HDAC inhibition by ECN than SFN, which is the most commonly studied of cruciferous vegetable phytochemical metabolites. Perhaps a stronger focus on ECN as a potential epigenetic modulator would be fruitful as it can be found at high concentrations in other cruciferous vegetables such as arugula [41, 42]. To the best of our knowledge, this is the first report of HDAC inhibition by erucin.…”
Section: Discussionmentioning
confidence: 91%
“…p53 status) and epigenetic profiles. Moreover, ITCs were shown to exhibit their cytotoxic effects selectively towards tumor cells in several cancer models [ 23 , 24 ]. Consistent with these studies, both the ITCs exhibited growth inhibitory effects selectively towards cancer cells when compared with normal human bronchial epithelial cells (HBECs).…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, numerous studies in human tumor xenograft models and tumor cell lines demonstrated tumor-specific growth inhibitory properties for ITCs [ 20 , 21 ]. Increasing evidence is also available for their ability to cause cell cycle arrest, induce apoptosis, suppress IκB and Nf-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling and binding to thiol-reactive groups of several cellular targets such as DNA topoisomerase 2, p53 and tubulins [ 18 , 21 , 22 , 23 ]. These studies strongly advocate for the existence of additional mechanisms that are independent from carcinogen detoxification for their cancer preventive properties.…”
Section: Introductionmentioning
confidence: 99%
“…In addition to the cytoprotective effect, SFN has also been shown to exhibit cytotoxic effects including promoting ER stress and cell death [11][12][13] ; disrupting mitochondria 14 , tubulin and microtubule function [15][16][17] ; inducing DNA damage 18 , apoptosis and cell cycle arrest [19][20][21][22] ; inhibiting telomerase activity 11,23 and protein-protein interaction in Hsp90 complex 24 . The complex bioactivities of SFN and subsequent cellular responses are highly dependent upon the dose and duration of SFN treatment.…”
Section: Introductionmentioning
confidence: 99%